Top Story

BMI should not influence chemotherapy dose reductions for ovarian cancer

BMI should not influence chemotherapy dose reductions for ovarian cancer
July 7, 2015

Women with ovarian cancer who received paclitaxel and carboplatin dose reductions experienced poorer survival regardless of their body size, according to study results.

However, body size predicted the receipt of chemotherapy dose reductions, results also showed. These results suggest chemotherapy dose reduction for patients with ovarian cancer should not be based on a woman’s body size or their BMI, according to the researchers.

In the Journals

Extended anticoagulation beneficial after pulmonary embolism; stops when treatment ends

July 7, 2015
Patients who experience a first pulmonary embolism may benefit from anticoagulation therapy for up to 2 years after the unprovoked episode, although the benefits of…
In the Journals

History of melanoma, actinic skin lesions linked to better use of sun protection

July 7, 2015
A recent population-based study has revealed that people with a previously confirmed melanoma diagnosis and/or treated actinic lesions were more likely to regularly use…
Joann Elmore In the Journals

Mammography screening associated with increase in small breast cancers

July 7, 2015
Mammography screening has led to increased detection of small breast cancers without a concomitant decline in the detection of larger breast cancers or breast cancer…
Alexi Wright In the Journals

ASCO endorses ASTRO recommendations for postoperative radiation in endometrial cancer

July 6, 2015
ASCO has endorsed guidelines from the American Society of Radiation Oncology on radiation therapy after surgery for patients with endometrial cancer, according to an…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan
morganatic-roan